Global Omega-3 Concentrates Market Size By Type (Triglyceride, Ethyl Ester), By Application (Food and Beverage Industry, Pharmaceutical Industry), By Region, And Segment Forecasts, 2023 to 2032

The Global Omega-3 Concentrates Market was valued at USD 2.4 billion in 2023 and is projected to surpass USD 4.8 billion by 2031, growing at a compound annual growth rate (CAGR) of 9.1% during the forecast period from 2023 to 2031. Omega-3 concentrates—especially EPA and DHA—are gaining traction globally due to their scientifically backed health benefits, including cardiovascular support, cognitive function, and anti-inflammatory properties. The demand is further fueled by rising health awareness, a growing aging population, and the increasing use of omega-3 concentrates in pharmaceuticals, dietary supplements, and functional foods.

Drivers:

1. Rising Awareness of Preventive Healthcare:

The global shift toward preventive health and wellness has significantly boosted demand for omega-3 concentrates. These supplements are recognized for supporting heart, brain, and joint health, driving their inclusion in daily nutritional regimens.

2. Expansion of Nutraceuticals and Functional Foods:

The integration of omega-3 concentrates into functional foods, beverages, and nutraceuticals is rapidly increasing, especially in North America and Europe, as consumers seek natural alternatives to traditional medications.

3. Technological Advancements in Concentration Techniques:

Innovations in extraction and purification technologies have enabled manufacturers to produce high-purity omega-3 concentrates with reduced fishy odor and taste, thereby improving consumer acceptance and product variety.

Restraints:

1. Fluctuating Raw Material Supply:

Omega-3 concentrates are primarily derived from marine sources like anchovies and sardines. Variability in fish oil supply due to environmental regulations and overfishing poses a risk to consistent production.

2. High Processing Costs:

The purification and concentration of omega-3 fatty acids require sophisticated equipment and techniques, increasing production costs and potentially limiting accessibility in price-sensitive markets.

Opportunity:

1. Increasing Demand from the Pharmaceutical Industry:

Omega-3 concentrates are increasingly being used in the formulation of prescription drugs aimed at managing hypertriglyceridemia and other cardiovascular conditions, offering a significant opportunity for market expansion.

2. Emerging Vegan and Algae-Based Alternatives:

The growing plant-based trend is driving innovation in algae-derived omega-3 concentrates. These sustainable and vegan-friendly sources offer an alternative to marine-based options, appealing to a broader consumer base.

Market by System Type Insights:

Based on concentration type, the High EPA Concentrates segment dominated the market in 2023. The segment’s growth is attributed to the increasing demand for EPA-rich products in managing inflammation, heart health, and mental well-being. However, the High DHA Concentrates segment is expected to register the fastest growth, especially due to rising demand in infant nutrition and neurological support formulations.

Market by End-use Insights:

In terms of end-use, the Dietary Supplements segment accounted for the largest market share in 2023, supported by growing consumer interest in preventive health. The Pharmaceutical segment is projected to witness substantial growth over the forecast period, driven by clinical applications and prescription use of high-purity omega-3 concentrates.

Market by Regional Insights:

North America led the market in 2023, supported by robust demand for health supplements and a well-established nutraceutical industry. Meanwhile, Asia-Pacific is expected to exhibit the fastest growth rate during the forecast period, driven by increasing health awareness, rising middle-class income, and expanding product accessibility in countries like China, India, and Japan.

Competitive Scenario:

Key players in the global Omega-3 Concentrates Market include:

BASF SE

Koninklijke DSM N.V.

Croda International Plc

GC Rieber VivoMega

Epax Norway AS

KD Pharma Group

Orkla Health

Nordic Naturals

Pharmavite LLC

Omega Protein Corporation

These companies focus on technological innovation, capacity expansions, and strategic alliances to gain competitive advantages. For example:

In 2023, DSM announced the development of a new algae-based omega-3 concentrate aimed at expanding its vegan product portfolio.

In 2024, BASF SE entered into a partnership with a biotechnology startup to improve sustainable sourcing of marine oils.

In 2025, GC Rieber VivoMega launched an ultra-refined, odorless omega-3 concentrate specifically tailored for pharmaceutical-grade applications.

Scope of Work – Global Omega-3 Concentrates Market

Key Market Developments:

2023: DSM launched its next-generation algae-based omega-3 concentrate, targeting vegan consumers.

2024: BASF SE announced strategic collaboration for sustainable omega-3 sourcing.

2025: GC Rieber VivoMega introduced a pharmaceutical-grade, odor-neutral omega-3 product.

FAQs:

1) What is the current market size of the Global Omega-3 Concentrates Market?

The market size was valued at USD 2.4 billion in 2023.

2) What is the major growth driver of the Global Omega-3 Concentrates Market?

The major growth driver is the rising global focus on preventive healthcare and heart-healthy nutrition.

3) Which is the largest region during the forecast period in the Global Omega-3 Concentrates Market?

North America is the largest region, owing to advanced nutraceutical infrastructure and high supplement adoption rates.

4) Which segment accounted for the largest market share in Global Omega-3 Concentrates Market?

The dietary supplements segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Omega-3 Concentrates Market?

Key players include BASF SE, DSM, Croda, GC Rieber VivoMega, Epax Norway AS, and KD Pharma Group.